Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
USV (India)
h-index: 12
Total citations: 492
Total papers: 86
Homepage:
https://www.usvindia.com/
Recent papers from USV (India)
Pioglitazone-Mediated Reduction of Ectopic Fat in Metabolic Dysfunction-Associated Steatotic Liver Disease
Cureus · 2026
Harmonization and fragmentation in competing ESG materiality regimes and their implications for sustainability reporting
Discover Global Society · 2026
AI Sabbatical: A conceptual framework for cognitive sustainability in AI-augmented knowledge work
Human Systems Management · 2026
Expert Consensus on the Clinical Use of the Dapagliflozin–Pioglitazone Fixed-Dose Combination in Adults with Type 2 Diabetes Mellitus in India: PRO-3 Study
Journal of Diabetology · 2026
Withania somnifera root extract reduces susceptibility of the model worm Caenorhabditis elegans to different types of stressors
Drug Target Insights · 2026
A Systematic Review on the Combination of Glipizide and Metformin for Type Two Diabetes
Chronicle of Diabetes Research and Practice · 2026
The IQ-SET India Study: A Multicentric, Retrospective, Observational Data Analysis Evaluating the Safety, Efficacy, and Tolerability of InsuQuick® (Insulin Aspart 100 U/mL) in Subjects with Type 2 Diabetes Mellitus
Journal of Diabetology · 2026
Assessing Insights Regarding Clinical Utility and Optimal Applicability of Glipizide + Metformin Fixed-Dose Combination in Elderly Type 2 Diabetes Mellitus Indian Patients (ASHA-Elderly India)
Chronicle of Diabetes Research and Practice · 2026
Expert Consensus and Physician Perspectives on a Low-dose Triple Fixed-dose Combination for Type 2 Diabetes in India
Journal of the Association of Physicians of India · 2026
Glimepiride and Metformin Fixed-Dose Combination (FDC) along with Metformin + Dapagliflozin + Sitagliptin FDC in T2DM Patients with High Risk for Cardiovascular Disease: GRACE-CVD Study
Journal of Diabetology · 2026
Hypertension management in chronic coronary syndrome: Insights and consensus from Indian cardiologists
Heart India · 2026
Efficacy and safety of fixed-dose dapagliflozin–pioglitazone in Indian adults with type 2 diabetes: a phase 3 PRO-1 trial
Diabetology & Metabolic Syndrome · 2026
High-intensity lipid-lowering therapy with rosuvastatin and ezetimibe for uncontrolled dyslipidemia in Indian patients: A real-world study (HILL-INDIA study)
Heart India · 2026
Safety and Tolerability of Withania somnifera Root Extract in Healthy Male Participants: A Pilot Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
Food Science & Nutrition · 2025
Withania somnifera root extract reduces susceptibility of the model worm Caenorhabditis elegans to different types of stressors
2025
Rational Use of Dapagliflozin 5 mg: Real-World Prescribing Trends and a Practical ABCDEF Framework for Therapy Personalization
Journal of Diabetology · 2025
Clinician-led Digital Innovations in Diabetes Care: Insights from the 2025 Jothydev’s Professional Education Forum–USV Technology Awards in India
International Journal of Diabetes and Technology · 2025
Real-World Evaluation of Early Initiation of Dapagliflozin and Sitagliptin Combination Therapy in the Management of Type 2 Diabetes Mellitus (REALIZE Study)
Cureus · 2025
BRIDGE-DS study: a multicenter, observational, retrospective analysis of dapagliflozin and sitagliptin combination on modifiable cardiovascular risk factors in T2DM patients with ASCVD or high cardiovascular risk
Cardiovascular Endocrinology & Metabolism · 2025
Evaluation of Deficiency of Vitamin D and Advantages of Supplementation of Vitamin D in COVID-19 Infections: A Narrative Review.
2025